Orbifloxacin
规格
113617-63-3CAS 号
638-855-2EC 号
1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic acidIUPAC 名称
C19H20F3N3O3化学式
395.4 g/mol分子量
ORBIFLOXACIN; 113617-63-3; Orbax; orbifloxacine; orbifloxacino; DTXSID7046201; NSC-758614; 660932TPY6; 1-cyclopropyl-7-((3S,5R)-3,5-dimethylpiperazin-1-yl)-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; orbifloxacinum; Orbax Tablets; RefChem:57814; DTXCID901777786; 1-cyclopropyl-7-((3S,5R)-3,5-dimethylpiperazin-4-ium-1-yl)-5,6,8-trifluoro-4-oxoquinoline-3-carboxylate; 638-855-2; MFCD00864858; 3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-5,6,8-trifluoro-1,4-dihydro-4-oxo-, rel-; 1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic acid; NCGC00160518-01; CP-104354; 1-cyclopropyl-7-((3R,5S)-3,5-dimethylpiperazin-1-yl)-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 1-Cyclopropyl-7-(cis-3,5-dimethylpiperazin-1-yl)-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 1-cyclopropyl-7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; DTXCID5026201; SMR000544203; Orbifloxacin [INN]; CAS-113617-63-3; SR-01000790054; Orbifloxacin [USP:INN:BAN]; UNII-660932TPY6; Orbifloxacin CRS; Orbax (veterinary); Orbifloxacin; 1-Cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; Orbifloxacin (Standard); SpecPlus_000366; CP 104354; Orbifloxacin (USP/INN); ORBIFLOXACIN [MI]; Orbax [veterinary] (TN); ORBIFLOXACIN [JAN]; ORBIFLOXACIN [MART.]; MLS000766847; MLS001216436; DivK1c_006462; ORBIFLOXACIN [USP-RS]; SCHEMBL125116; CHEMBL295433; orb1226937; orb1310751; orb3139971; SCHEMBL29420860; GTPL13671; HY-B0915R; KBio1_001406; MSK5743; ORBIFLOXACIN [GREEN BOOK]; Orbifloxacin impurity mixture CRS; CHEBI:183823; HMS2875G03; HMS3264M13; Pharmakon1600-01503711; ORBIFLOXACIN [USP IMPURITY]; HY-B0915; RKL10078; ORBIFLOXACIN [USP MONOGRAPH]; Tox21_111867; MSK5743-100D; MSK5743-100M; NSC758614; s4150; AKOS015969739; Tox21_111867_1; AO40692; AT-4526; CCG-213832; CS-4384; DB11443; KS-5013; NSC 758614; NCGC00160518-02; NCGC00160518-03; NCGC00160518-04; 1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic acid; 1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-quinoline-3-carboxylic acid; SY066864; Orbifloxacin Solution in DMSO, 100ug/mL; SBI-0207085.P001; CP-104,354; O0516; O6805; Orbifloxacin Solution in Methanol, 100ug/mL; D08299; D91881; Orbifloxacin for veterinary use [EP monograph]; AB00833179_04; AB00833179_05; Orbifloxacin, VETRANAL(TM), analytical standard; F842854; Q7100015; SR-01000790054-2; SR-01000790054-3; BRD-K63001556-001-03-9; BRD-K63001556-001-08-8; BRD-K63001556-001-09-6; Orbifloxacin Working Standard (Secondary Reference Standard); Orbifloxacin, European Pharmacopoeia (EP) Reference Standard; Orbifloxacin, United States Pharmacopeia (USP) Reference Standard; 1-cyclopropyl-5,6,8-trifluoro-7-(cis-3,5-dimethyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid; 1-Cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-5,6,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; 1-CYCLOPROPYL-7-(CIS-3,5-DIMETHYL-1-PIPERAZINYL)-5,6,8-TRIFLUORO-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID; 1-Cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-4-ium-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylate; 1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-5,6,8-triluoro-4-oxoquinoline-3-carboxylic acid同义词
